Anixa Biosciences Inc. (ANIX)
NASDAQ: ANIX
· Real-Time Price · USD
3.64
-0.11 (-2.93%)
At close: Jun 17, 2025, 1:49 PM
-2.93% (1D)
| Bid | 3.64 |
| Market Cap | 117.31M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -12.48M |
| EPS (ttm) | -0.37 |
| PE Ratio (ttm) | -9.84 |
| Forward PE | -9.47 |
| Analyst | Buy |
| Ask | 3.65 |
| Volume | 125,320 |
| Avg. Volume (20D) | 103,625 |
| Open | 3.79 |
| Previous Close | 3.75 |
| Day's Range | 3.64 - 3.78 |
| 52-Week Range | 2.07 - 4.20 |
| Beta | 0.33 |
About ANIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANIX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANIX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+23.19%
Anixa Biosciences shares are trading higher after ...
Unlock content with
Pro Subscription
2 weeks ago
+12.45%
Anixa Biosciences shares are trading higher after the company announced it completed enrollment for its Phase 1 breast cancer vaccine clinical trial.
